Please assess the completion status of the following clinical trial:

Trial Title: Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Gastric polyp with current infection of H. pylori~* Gastric polyp size with 3mm-10mm~* Age of 20 yr - 70yr~Exclusion Criteria:~* Gastric ulcer ir duodenal ulcer (healing stage or acute stage)~* Use of PPI within 4weeks~* Liver cirrhosis, renal insufficiency, other serious chronic or acute disease~* Current infection of other bacteria, virus, or fungus~* Any cancer, psychologic disease~* Heavy drinker~* Drug abuser~* Pregnant women~* Penicillin allergy~* Use of digoxin, antifungal, wafarin~* Previous H. pylori eradication~* Gastric polyp with bleeding or malignant transformation~* Tiny polyp less than 3mm.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- eradictaion (Type: EXPERIMENTAL): H. pylori eradication group
- non-eradication (Type: NO_INTERVENTION): H. pylori non-eradication group

Based on this trial design, predict the completion outcome and termination type (if applicable).